pNL3.2.NF-kB-RE[NlucP/NF-kB-RE/Hygro] Vector, 20microg

by Promega


  • N1111 | pNL3.2.NF kB RE NlucP NF kB RE Hygro Ve
  • N1111 | pNL3.2.NF kB RE NlucP NF kB RE Hygro Ve
Average lead time: Call for Lead Time
ADD TO CART
Need Assistance?

Jump to Section
Product Description
NanoLuc (Nluc) luciferase is a small enzyme (19.1kDa) engineered for optimal performance as a luminescent reporter. The enzyme is about 100-fold brighter than either firefly (Photinus pyralis) or Renilla reniformis luciferase using a novel substrate, furimazine, to produce high intensity, glow-type luminescence. The luminescent reaction is ATP-independent and designed to suppress background luminescence for maximal assay sensitivity. For use as a genetic reporter, multiple forms of NanoLuc luciferase have been configured to meet differing experimental objectives. NanoLuc-PEST (NlucP) present in pNL3.2.NF-?B-RE[NlucP/NF-?B-RE/Hygro] Vector closely couples protein expression to changes in transcriptional activity and increased signal-to background ratios. Use the pNL3.2.NF-?B-RE[NlucP/NF-?B-RE/Hygro] Vector to assess the response to cellular changes in the nuclear factor kappaB. Luminescence is linearly proportional to the amount of NanoLuc protein over a 1,000,000-fold concentration range, with a signal half-life >/=2 hours when detected with Nano-Glo Luciferase Assay Reagent. NanoLuc luciferase possesses a number of physical properties that make it an excellent reporter protein: 1) very small, monomeric enzyme (171 amino acids; 513bp); 2) high thermal stability (Tm = 60°C); 3) active over a broad pH range (pH 6-8); 4) no post-translational modifications or disulfide bonds; 5) uniform distribution in cells; 6) emission spectrum well suited for bioluminescence resonance energy transfer (BRET; lambdamax = 465nM). NanoLuc luciferase is made available in a variety of plasmids designed for use in reporter gene assays of transcriptional control and with each of the NanoLuc forms (unfused Nluc, PEST destabilized NlucP, and secreted secNluc). The different pNL variations are designed for the following: 1) pNL1: cloning of a known or putative promoter region; 2) pNL2: cloning of a known or putative promoter region and establishment of a stable cell line through Hygromycin selection; 3) pNL3: cloning of a binding site or response element not in need of a basic promoter (such as are present in the pNL3.2.NF-kB-RE vector); 4) Control plasmids for the unfused, PEST-destabilized and secreted Nluc forms also are available. The pNL vector series uses a pGL4-based backbone for easy sequence transfer from existing plasmids. This backbone design also reduces anomalous results by removing many transcription factor binding sites and other potential regulatory elements. The NlucP gene is codon optimized and has removed many potential regulatory elements or other undesirable features (such as common restriction enzyme sites).
Specifications
Inventory Number:
PRMN1111EA
Part Number:
N1111
Supplier:
Promega
Supplier's Lead Time:
Call for Lead Time
Quantity:
1 per EA
Contract Availability:
GSA
Country of Origin:
United States
Refrigerated/Frozen:
Frozen
Size:
20microg
Additional Information

Contact the GSS Team Today!
GSS-Sales@govsci.com | 800.248.8030 | www.govsci.com

Government Scientific Source
ISO 9001:2015 Certified
Copyright 2024, Government Scientific Source. All Rights Reserved.